Immunovant, Inc. (IMVT) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q1 EPS of ($0.71), $0.01 worse than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank monitors UK auto sales as Chinese exports grow
- UBS says bull market has further to run
- Arena Group to rename as Paradium.AI, ticker changing to PAAI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
